ATE450261T1 - GABAPENTIN COMPOSITIONS FOR INJECTION - Google Patents

GABAPENTIN COMPOSITIONS FOR INJECTION

Info

Publication number
ATE450261T1
ATE450261T1 AT04795782T AT04795782T ATE450261T1 AT E450261 T1 ATE450261 T1 AT E450261T1 AT 04795782 T AT04795782 T AT 04795782T AT 04795782 T AT04795782 T AT 04795782T AT E450261 T1 ATE450261 T1 AT E450261T1
Authority
AT
Austria
Prior art keywords
gabapentin
compositions containing
injectable compositions
containing gabapentin
injection
Prior art date
Application number
AT04795782T
Other languages
German (de)
Inventor
Dennis Elsberry
David Clarahan
Linda Page
Deanna Lane
Keith Hildebrand
Jayantha Ratnayake
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/808,129 external-priority patent/US20050004221A1/en
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority claimed from PCT/US2004/034668 external-priority patent/WO2005041976A2/en
Application granted granted Critical
Publication of ATE450261T1 publication Critical patent/ATE450261T1/en

Links

Abstract

Injectable compositions containing gabapentin and processes for preparing sterile injectable compositions containing gabapentin are discussed. The process includes subjecting the compositions to heat. Heating results in increased production of gabapentin lactam, which has previously been shown to be toxic. Surprisingly, heated injectable compositions containing gabapentin are found to be non-toxic when administered intrathecally. Thus, heating for the purposes of sterilization or to assure sterility provides a viable option in the production of injectable compositions containing gabapentin.
AT04795782T 2003-10-23 2004-10-21 GABAPENTIN COMPOSITIONS FOR INJECTION ATE450261T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51368203P 2003-10-23 2003-10-23
US51368103P 2003-10-23 2003-10-23
US10/808,129 US20050004221A1 (en) 2003-07-01 2004-03-24 Intrathecal gabapentin compositions
PCT/US2004/034668 WO2005041976A2 (en) 2003-10-23 2004-10-21 Injectable gabapentin compositions

Publications (1)

Publication Number Publication Date
ATE450261T1 true ATE450261T1 (en) 2009-12-15

Family

ID=41402068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04795782T ATE450261T1 (en) 2003-10-23 2004-10-21 GABAPENTIN COMPOSITIONS FOR INJECTION

Country Status (4)

Country Link
CN (1) CN1870974B (en)
AT (1) ATE450261T1 (en)
DE (1) DE602004024437D1 (en)
HK (1) HK1097460A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101340792B (en) * 2007-07-04 2011-04-27 华硕电脑股份有限公司 Lid-turning mechanism and electronic apparatus applying the same
CN110652600B (en) * 2019-09-27 2020-07-28 浙江都邦药业股份有限公司 Multistage sterilization and disinfection equipment for injection and disinfection process thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2473536A1 (en) * 2002-01-16 2003-07-31 Endo Pharmaceuticals, Inc. Pharmaceutical composition and method for treating disorders of the central nervous system

Also Published As

Publication number Publication date
CN1870974A (en) 2006-11-29
HK1097460A1 (en) 2007-06-29
CN1870974B (en) 2010-06-23
DE602004024437D1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
MX2022013264A (en) Coronavirus vaccine.
CY1115617T1 (en) USE OF PATIENTS IN TREATMENT OF DISEASES THAT ARE CONCERNED WITH THE PROTEIN TOWARDS WHICH INCLUDE THE DISEASE
PT2155221E (en) A method for modifying polyphenol containing plant materials and medical uses of modified polyphenol plant containing materials
MX2009012978A (en) Method for silk fibroin gelation using sonication.
MX338879B (en) Dilute filtration sterilization process for viscoelastic biopolymers.
DE69735851D1 (en) METHOD FOR ACTIVATING HUMAN, ANTIGEN-ACTIVATING CELLS, ACTIVATED HUMAN, ANTIGEN-ACTIVATING CELLS, AND APPLICATIONS THEREOF
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
SE9903331D0 (en) Method and apparatus for sterilizing a heat sensitive fluid
UA88481C2 (en) Donepezil fumarate suitable for the preparation of pharmaceutical compositions
DE602004031134D1 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE USE OF LEVODOPA AND CARBIDOPA
EA201070046A1 (en) METHOD FOR OBTAINING A MEDICINE CONTAINING TADALAFIL
MX2010001145A (en) Method and compound for the treatment of articular diseases or articular pain, or for the treatment of skin for aesthetic or other purposes, and the method of preparation of the compound.
TW200716224A (en) Method of indentifying therapeutic targets for the treatment of vulvovaginal atrophy
CY1108401T1 (en) PYRROLOIMIDAZOLO PRODUCERS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE AND USE AS A NOOTROPIC FACTOR
TW200517389A (en) Biaryloxymethylarenecarboxylic acids
BR112021019663A2 (en) Method for producing therapeutic microvesicles, probiotic composition, therapeutic microvesicles, and bacterial strain
DE602007014019D1 (en) PROCESS FOR RADIATION STERILIZATION OF PLASTIC PACKAGING MATERIAL FOR INSULIN
ATE450261T1 (en) GABAPENTIN COMPOSITIONS FOR INJECTION
WO2007072514A8 (en) Apparatus and method for subcutaneous gas delivery for therapeutic purpose
UA92604C2 (en) Stannsoporfin composition having a physiological osmolarity and use thereof
WO2005041977A3 (en) Process for producing injectable gabapentin compositions
ATE479423T1 (en) DEVICE FOR THE TOPICAL APPLICATION OF MEDICAL OZONE FOR THE TREATMENT OF DISEASES OF THE ORAL CAVITY
ZA200908583B (en) Substituted (oxazolidinon-5-yl-methyl)-2-thiophene-carboxamides and use thereof in the field of blood coagulation
ES2421721T3 (en) Food material and process to produce it, and food similar to cheese and process to produce it
EP1637547B8 (en) Process for the preparation of a polymeric hydrogel based on a highly purified polyvinylalcohol and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties